11th Circ. Nixes Procaps' Bid To Revive $255M Antitrust Suit
"Patheon Inc. didn’t make its joint venture with Procaps SA anti-competitive by buying one of Procaps' rivals in the softgel capsule business because there has been no actual harm from the acquisition, the Eleventh Circuit said Friday in upholding a district court’s dismissal of Procaps' $255 million suit."
Related contacts
This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may have been generated with the assistance of artificial intelligence (AI) in accordance with our AI Principles, may be considered Attorney Advertising and is subject to our legal notices.